Search

146 results for “review”

• Review ArticleOpen Access

  An Update on the Pharmacological Aspects of Vaccines and Antivirals for the Management of Monkeypox

  Jerin James, Porkodi A, Kala P, Jamuna Rani, Sathyanarayanan V

  Vol. 13 · Issue 4 · pp. 341–348

  https://doi.org/10.1177/0976500X231156733
  Full text ↗PDF

• Review ArticleOpen Access

  Dengue Virus: Molecular Biology and Recent Developments in Control Strategies, Prevention, Management, and Therapeutics

  Almonther Abdullah Hershan

  Vol. 14 · Issue 2 · pp. 107–124

  https://doi.org/10.1177/0976500X231204401
  Full text ↗PDF

• Review ArticleOpen Access

  Metabolic syndrome in schizophrenia: Differences between antipsychotic‑naïve and treated patients

  Rakesh K. Chadda, Prashanth Ramshankar, Koushik S. Deb, Mamta Sood

  Vol. 4 · Issue 3 · pp. 176–176

  https://doi.org/10.4103/0976-500X.114596
  Full text ↗PDF

• Review ArticleOpen Access

  Lesinurad: A significant advancement or just another addition to existing therapies of gout?

  Ajay Gupta, Pramod Kumar Sharma, Arup Kumar Misra, Surjit Singh

  Vol. 7 · Issue 4 · pp. 155–158

  https://doi.org/10.4103/0976-500X.195897
  Full text ↗PDF

• Case ReviewOpen Access

  The safety of ketoprofen in different ages

  Claudia Carbone, Pierandrea Rende, Pasquale Comberiati, Domenico Carnovale, Maria Mammì, Giovambattista De Sarro

  Vol. 4 · Issue Supplement 1 · pp. S99–S100

  https://doi.org/10.4103/0976-500X.120967
  Full text ↗PDF

• Review ArticleOpen Access

  Tapinarof: A Felicitous Discovery in Psoriasis Treatment

  Indumathi Prabath, Subhiksha Subramanian, Jamuna Rani

  Vol. 13 · Issue 3 · pp. 222–228

  https://doi.org/10.1177/0976500X221130851
  Full text ↗PDF

• Case ReviewOpen Access

  Nexavar®-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012

  Felisa Cilurzo, Orietta Staltari, Marinella Patanè, Michele Ammendola, Caterina Garaffo, Eugenio Donato Paola

  Vol. 4 · Issue 1 · pp. S86–S86

  https://doi.org/10.4103/0976-500X.120971
  Full text ↗PDF

• Review ArticleOpen Access

  A Comparative Study of Chromium: Therapeutic Uses and Toxicological Effects on Human Health

  Anaiska Ray, Jayshri Sadashiv Jankar

  Vol. 13 · Issue 3 · pp. 239–245

  https://doi.org/10.1177/0976500X221128646
  Full text ↗PDF

• Mini ReviewOpen Access

  Anti-vascular endothelial growth factor drugs safety and efficacy in ophthalmic diseases

  Pasquale Ventrice, Christian Leporini, Jose’ Francisco Aloe, Ettore Greco, Giacomo Leuzzi, Giuseppina Marrazzo, Giovanni Battista Scorcia, Donatella Bruzzichesi, Varano Nicola, Vincenzo Scorcia

  Vol. 4 · Issue Supplement 1 · pp. S38–S39

  https://doi.org/10.4103/0976-500X.120947
  Full text ↗PDF

• Review ArticleOpen Access

  Riociguat: Something new in pulmonary hypertension therapeutics?

  Elangovan Shanmugam, Amrita Jena, Melvin George

  Vol. 6 · Issue 1 · pp. 3–6

  https://doi.org/10.4103/0976-500X.149132
  Full text ↗PDF

• Case ReviewOpen Access

  Corticosteroid-related central nervous system side effects

  Miriam Ciriaco, Pasquale Ventrice, Gaetano Russo, Maria Scicchitano, Giovanni Mazzitello, Francesca Scicchitano, Emilio Russo

  Vol. 4 · Issue Supplement 1 · pp. S94–S95

  https://doi.org/10.4103/0976-500X.120975
  Full text ↗PDF

• Review ArticleOpen Access

  The Role of TGF-β in Cognitive Decline Associated with Radiotherapy in Brain Tumor

  G. S. Swarna Bindu, Dithu Thekkekkara, T. Lakshmi Narayanan, Jiju Narayanan, Sri Harsha Chalasani, S. N. Manjula

  Vol. 13 · Issue 2 · pp. 125–134

  https://doi.org/10.1177/0976500X221107503
  Full text ↗PDF

• Review ArticleOpen Access

  Treatment Considerations and Pharmacist Collaborative Care in Diabetic Ketoacidosis Management

  Alanood Algarni

  Vol. 13 · Issue 3 · pp. 215–221

  https://doi.org/10.1177/0976500X221128643
  Full text ↗PDF

• Review ArticleOpen Access

  Rituximab, a Safer Option for Rheumatoid Arthritis: A Comparison of the Reported Adverse Events of Approved Monoclonal Antibodies

  Sweety Sharma, Somnath Basu, Ramesh K. Goyal, Parbhat K. Sahoo, Rajani Mathur

  Vol. 13 · Issue 4 · pp. 330–340

  https://doi.org/10.1177/0976500X231154743
  Full text ↗PDF

• Review ArticleOpen Access

  Pharmacovigilance in Italy: An overview

  Carmela Mazzitello, Stefania Esposito, Adele E. De Francesco, Annalisa Capuano, Emilio Russo, Giovambattista De Sarro

  Vol. 4 · Issue Supplement 1 · pp. S20–S21

  https://doi.org/10.4103/0976-500X.120942
  Full text ↗PDF

• Review ArticleOpen Access

  Neurotoxicity by Hypoxia an Intermediate Between Alpha-synuclein and Mitochondrial Dysfunction in Parkinson’s Disease

  Jagdish Chand, Hannah Lalengzuali Fanai, A. S. Antony, Gomathy Subramanian

  Vol. 15 · Issue 3 · pp. 253–263

  https://doi.org/10.1177/0976500X241253648
  Full text ↗PDF

• Review ArticleOpen Access

  Exploring Interleukin-6 Inhibitor Antibodies in Combatting SARS-CoV-2 and its Mutated Variants: Challenges and Future Directions

  Mohammed Ali Bakkari, Gassem Ghoal, Fahad Y. Sabei, Awaji Y. Safhi, Sivakumar S. Moni

  Vol. 16 · Issue 4 · pp. 362–374

  https://doi.org/10.1177/0976500X251316939
  Full text ↗PDF

• Review ArticleOpen Access

  Epilepsy: Novel therapeutic targets

  Ashish P. Anovadiya, Jayesh J. Sanmukhani, C. B. Tripathi

  Vol. 3 · Issue 2 · pp. 112–117

  https://doi.org/10.4103/0976-500X.95505
  Full text ↗PDF

• Review ArticleOpen Access

  Adipokine Modulation in Endometrial Hyperplasia by Polyunsaturated Fatty Acids

  Athuru Supriya, Ammu V. V. V. Ravi Kiran, Praveen Thaggikuppe Krishnamurthy

  Vol. 15 · Issue 3 · pp. 237–252

  https://doi.org/10.1177/0976500X241259578
  Full text ↗PDF

• Mini ReviewOpen Access

  Iptakalim: A novel multi-utility potassium channel opener

  (Kir6.1s) (Kir6.1s), regulatory sulphonylurea subunits (SUR).[3] IPT shows high selectivity for cardiac KATP (SUR2A/Kir6.2), vascular KATP (SUR2B/Kir6.1 or SUR6B/Kir6.2). Because

  Vol. 3 · Issue 1 · pp. 12–14

  https://doi.org/10.4103/0976-500X.92495
  Full text ↗PDF